Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States-Reference-Cited by-同舟云学术

Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States

Published:2016-09-01 Issue:9 Volume:2 Page:1236
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Falchook Aaron D.¹,Basak Ramsankar¹,Mohiuddin Jahan J.¹,Chen Ronald C.²

Affiliation:

1. Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill

2. Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill2University of North Carolina–Lineberger Comprehensive Cancer Center, Chapel Hill

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data;BMC Cancer;2022-06-07

2. Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer;Cancer Medicine;2022-03-16

3. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer;European Urology Oncology;2021-04

4. Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer;Strahlentherapie und Onkologie;2019-11-29

5. Variations in patterns of concurrent androgen deprivation therapy use based on dose escalation with external beam radiotherapy vs. brachytherapy boost for prostate cancer;Brachytherapy;2019-05